Back to top

Ironwood CMO Michael Shetzline to retire, Jeffrey Silber to succeed

Ironwood (IRWD) Pharmaceuticals announced the retirement of Chief Medical Officer and Head of Research and Drug Development Dr. Michael Shetzline a...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Ironwood Pharmaceuticals, Inc. (IRWD)